Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
collaboration between AstraZeneca and Queen Mary University of London (QMUL). A Knowledge Transfer Partnership (KTP) is a collaborative program encouraging innovation by connecting businesses and universities, co
-
collaboration between AstraZeneca and Queen Mary University of London (QMUL). A Knowledge Transfer Partnership (KTP) is a collaborative program encouraging innovation by connecting businesses and universities, co
-
About the Opportunity About the Opportunity Northeastern University Pharmaceutical Industry Fellowships Program is a two-year experiential program designed to advance lifelong learning and the
-
Associate in collaboration between AstraZeneca and Queen Mary University of London (QMUL) within the domain of Artificial Intelligence for multimodal integration of multi-omics and imaging data. About the
-
Engineering and Informatics – Luddy School Location Indianapolis Position Summary The Indiana University (IU) School of Science and the Luddy School of Informatics, Computing, and Engineering at IU
-
AstraZeneca. About You We welcome applications from individuals with a wide range of backgrounds, experiences and career paths. You should be able to demonstrate: Essential Criteria: A PhD, or equivalent
-
, neuromuscular diseases and vaccinology. The Oxford Vaccine Group has gained international recognition for its pivotal role in vaccine development, including developing the Oxford-AstraZeneca COVID-19 vaccine
-
Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research
-
Type of Contract Temporary Job Status Full-time Is the job funded through the EU Research Framework Programme? Not funded by a EU programme Is the Job related to staff position within a Research
-
clinical trials. The group is led by Professor Teresa Lambe OBE, a Principal Investigator on the Oxford/AstraZeneca COVID‑19 vaccine programme, who co‑designed the vaccine in January 2020, led pre‑clinical